 Doxorubicin, cardiotoxic antineoplastic, disrupts cardiac-specific program gene expression (Kurabayashi, M., Dutta, S., Jeyaseelan, R., Kedes, L. (1995) Mol. Cell. Biol. 15, 6386-6397). identified neonatal rat cardiomyocyte mRNAs rapidly sensitive doxorubicin, congener daunomycin, including transcripts nuclear genes encoding enzymes critical production energy cardiomyocytes: ADP/ATP translocase, heart- muscle-specific isoform; Reiske iron-sulfur protein (RISP), ubiquitously expressed electron transport chain component; muscle isozyme phosphofructokinase. Loss mRNAs following doxorubicin daunomycin evident early 2 h precedes significant reduction intracellular ATP. ATP levels control cardiomyocytes (17.9 +/- 2.9 nM/mg protein) fall 14 h reach residual levels 10.4 +/- 0.9 nM (doxorubicin; p = <0.006) 6.7 +/- 1.9 nM (daunomycin; p = <0. 001) 24 h. Loss mRNAs generating ATP highly selective since mRNAs energy production enzymes, (cytochrome c, cytochrome b, malate dehydrogenase), genes important glycolysis (pyruvate kinase glyceraldehyde-3-phosphate dehydrogenase) unaffected even 24 48 h. drugs effect levels ubiquitously expressed RISP mRNA fibroblasts. findings could link doxorubicin-induced damage membranes signaling pathways 1) suppression transcripts encoding myofibrillar proteins proteins energy production pathways 2) depletion intracellular ATP stores, myofibrillar degeneration, related cardiotoxic effects.